Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Nonalcoholic Fatty Liver Disease Risk Factors Affect Liver-Related Outcomes After Direct-Acting Antiviral Treatment for Hepatitis C.

Digestive diseases and sciences - 1 Jul 2021

Benhammou Jihane N, Moon Andrew M, Pisegna Joseph R, Su Feng, Vutien Philip, Moylan Cynthia A, Ioannou George N

Abstract excerpt

INTRODUCTION: In hepatitis C (HCV) patients, obesity and/or diabetes may increase the risk of liver-related outcomes. We aimed to determine whether diabetes and/or obesity are associated with adverse outcomes in direct-acting antiviral (DAA)-treated HCV patients. METHODS: We conducted a retrospective study of 33,003 HCV-infected, DAA-treated Veterans between 2013 and 2015. Body mass index was used to categorize...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Antiviral Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diabetes Mellitus

Share to Hepacivirus

Share to Hepatitis C

Share to Non-alcoholic Fatty Liver Disease

Share to Obesity

Share to Risk Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 32654086
DOI: 10.1007/s10620-020-06457-2
PMCID: PMC7854862

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Nonalcoholic Fatty Liver Disease Risk Factors Affect Liver-Related Outcomes After Direct-Acting Antiviral Treatment for Hepatitis C.PMID 32654086Read ↗

Risk factors for Type 2 Diabetes Mellitus in Chronic Hepatitis C Virus-Infected Patients: A Retrospective Cohort Study in Southern ChinaSemantic proximity Read ↗

Virus Elimination by Direct-Acting Antiviral Agents Impacts Glucose Homeostasis in Chronic Hepatitis C Patients.Semantic proximity Read ↗

High incidence of hepatocarcinoma in patients with advanced fibrosis treated with direct-acting antiviral agents for hepatitis C: A real-world retrospective study.Semantic proximity Read ↗

Diabetes mellitus is associated with impaired response to antiviral therapy in chronic hepatitis C infection.Semantic proximity Read ↗

Hepatitis C virus infection and type 2 diabetes.Semantic proximity Read ↗

The importance and impact of recognizing metabolic dysfunction-associated fatty liver disease in patients with chronic hepatitis C.Semantic proximity Read ↗

Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C.Semantic proximity Read ↗

Impact Of Thyroid Dysfunction And Diabetes On Fibrosis And Steatosis Stages In Nonalcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Metabolic syndrome in patients with chronic hepatitis C virus genotype 1 infection who do not have obesity or type 2 diabetes.Semantic proximity Read ↗

Impact of sustained virological response on metabolic disorders in diabetic chronic hepatitis C virus patients after treatment with generic sofosbuvir and daclatasvir.Semantic proximity Read ↗

Effects of hepatitis C virus genotypes and viral load on glucose and lipid metabolism after sustained virological response with direct-acting antivirals.Semantic proximity Read ↗

Factors Associated with Insulin Resistance in Patients with Chronic HCV Genotype 1 Infection without Obesity or Type 2 Diabetes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.